King Pharmaceuticals Announces Date for Release of First Quarter 2008 Earnings

2008-04-09 23:49:43 -

www.kingpharm.com - King Pharmaceuticals, Inc. (NYSE: KG) reported today that the Company plans to announce financial results for the first quarter ended March 31, 2008 prior to the market open on Thursday, May 8, 2008. The Company also plans to provide a live conference call which may include discussion of the Company's financial results and expectations, marketed products, perspectives on the long-acting oxycodone marketplace, pipeline, strategy for growth, and other matters relating to its business beginning at 11:00 a.m. E.D.T. that same day. Interested persons may listen to the webcast by clicking on www.kingpharm.com/web_casts.asp. King will archive the webcast at this same link for not less than 14 days following the webcast for those unable to participate during the live webcast.

King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products in attractive markets and the strategic acquisition of branded products that can benefit from focused promotion and marketing and product life-cycle management.

This release contains forward-looking statements which reflect management's current views of future events and operations, including, but not limited to, statements pertaining to the anticipated date for release of the Company's financial results for the first quarter ended March 31, 2008. These forward-looking statements involve certain significant risks and uncertainties, and actual results may differ materially from the forward-looking statements. Some important factors which may cause results to differ include dependence on King's ability to release the Company's financial results for the first quarter ended March 31, 2008 as currently planned on May 8, 2008. Other important factors that may cause actual results to differ materially from the forward-looking statements are discussed in the "Risk Factors" section and other sections of King's Form 10-K for the year ended December 31, 2007, which is on file with the Securities and Exchange Commission. King does not undertake to publicly update or revise any of its forward-looking statements even if experience or future changes show that the indicated results or events will not be realized.

King Pharmaceuticals, Inc.
James E. Green, 423-989-8125
Executive Vice President, Corporate Affairs
or
David E. Robinson, 423-989-7045
Senior Director, Corporate Affairs